This is a prospective multicenter interventional observational study will be conducted in 4 major tertiary hospitals (Al-Sabah, Farwaniya , Mubarak Al-Kabeer and Jahra) in Kuwait .
Age
15–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Patients aged ≥18 years old ( those who are younger are involved after case based discussion)
2. Confirmed laboratory diagnosis with SARS-CoV-2 ,and admission diagnosis of SARS-CoV-2.
3. Patients with moderate or severe COVID-19 (moderate COVID-19 disease defined as the presence of any signs of pneumonia (fever, cough, dyspnoea fast breathing) including SpO2 \>90 on room air , but no signs of severe pneumonia (severe pneumonia have the above plus one of the following: respiratory rates \>30 breaths/minutes or SpO2\<90% on room air), or admission to intensive care unit (ICU) for respiratory support (i.e.high flow nasal cannula, non-invasive mechanical ventilation and intubation).
You may not be if
1. -Contraindication to transfusion (volume overload, history of anaphylaxis to blood products).
2. \- Patients presenting with acute severe multiorgan failure, hemodynamic instability.
3- Severe disseminated coagulopathy (DIC), septic shock and those with expected survival of less than 48 hours.
Clareo Health | COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients
